drugset / Trial / NCT01784900
Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab
RandomizedParallel-groupOpen-labelTreatment
Summary
Treatment by association of complete surgical excision of the lesions and intraperitoneal immunotherapy using Catumaxomab for patients with gastric peritoneal carcinomatosis
Timeline
- Start
- 2012-11
- Primary completion
- 2016-01
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Catumaxomab | Monoclonal antibody | 60 ug | Other |
| Subject | Catumaxomab | Monoclonal antibody | 80 ug | Other |